# BOOST - Benefit of Frequent Optimization After Cardiac Resynchronization Therapy Device Replacement

> **NCT00929474** · NA · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 17 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** QuickOpt - SJM CRT (Group 1)
- **DEVICE:** Control - SJM CRT (Group 2)

## Key facts

- **NCT ID:** NCT00929474
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-06
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00929474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00929474, "BOOST - Benefit of Frequent Optimization After Cardiac Resynchronization Therapy Device Replacement". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00929474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*